Quest PharmaTech (TSXV:QPT) Ending Cash Position : C$0.09 Mil (As of Oct. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Ending Cash Position?

Quest PharmaTech's Ending Cash Position for the quarter that ended in Oct. 2023 was C$0.09 Mil.

Quest PharmaTech's quarterly Ending Cash Position increased from Apr. 2023 (C$0.09 Mil) to Jul. 2023 (C$0.10 Mil) but then declined from Jul. 2023 (C$0.10 Mil) to Oct. 2023 (C$0.09 Mil).

Quest PharmaTech's annual Ending Cash Position increased from Jan. 2021 (C$0.20 Mil) to Jan. 2022 (C$0.26 Mil) and increased from Jan. 2022 (C$0.26 Mil) to Jan. 2023 (C$0.38 Mil).

Quest PharmaTech Ending Cash Position Historical Data

The historical data trend for Quest PharmaTech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Ending Cash Position Chart

Quest PharmaTech Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Ending Cash Position

Get a 7-Day Free Trial

0.35

2.15

0.20

0.26

0.38

Quest PharmaTech Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Ending Cash Position	Get a 7-Day Free Trial															0.48	0.38	0.09	0.10	0.09

Quest PharmaTech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Quest PharmaTech's Ending Cash Position for the fiscal year that ended in Jan. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.265	+	0.11
	=	0.38

Quest PharmaTech's Ending Cash Position for the quarter that ended in Oct. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.101	+	-0.007
	=	0.09

Quest PharmaTech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest PharmaTech (TSXV:QPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4

Website

http://www.questpharmatech.com

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Executives

Ragupathy Madiyalakan

Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines